Royal Bank Of Canada Athira Pharma, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,341 shares of ATHA stock, worth $5,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,341

Previous 55,409 84.95%

Holding current value

$5,421

Previous $146,000 97.95%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.42 - $3.43 $19,768 - $161,443	-47,068 Reduced 84.95%	8,341 $3,000
Q2 2024 Aug 14, 2024	BUY	$1.92 - $2.71 $90,927 - $128,340	47,358 Added 588.23%	55,409 $146,000
Q1 2024 Nov 05, 2024	SELL	$2.24 - $4.15 $106,081 - $196,535	-47,358 Reduced 85.47%	8,051 $22,000
Q1 2024 May 15, 2024	SELL	$2.24 - $4.15 $61,526 - $113,988	-27,467 Reduced 77.33%	8,051 $22,000
Q4 2023 Feb 14, 2024	BUY	$1.39 - $2.46 $46,687 - $82,626	33,588 Added 1740.31%	35,518 $86,000
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.16 $3,135 - $5,214	1,650 Added 589.29%	1,930 $3,000
Q2 2023 Aug 14, 2023	SELL	$2.36 - $3.59 $3,830 - $5,826	-1,623 Reduced 85.29%	280 $0
Q1 2023 May 15, 2023	SELL	$2.26 - $4.22 $7,580 - $14,153	-3,354 Reduced 63.8%	1,903 $4,000
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $4,738 - $6,370	1,717 Added 48.5%	5,257 $16,000
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $8,933 - $12,074	3,049 Added 620.98%	3,540 $10,000
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $27,745 - $135,992	-10,126 Reduced 95.38%	491 $2,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $133,011 - $200,555	-14,845 Reduced 58.3%	10,617 $143,000
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $697,387 - $1.25 Million	-76,051 Reduced 74.92%	25,462 $332,000
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $487,017 - $590,276	-53,226 Reduced 34.4%	101,513 $952,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $1.58 Million - $3.23 Million	154,739 New	154,739 $1.59 Million

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

112K

Put Options Held

68K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Athira Pharma, Inc. Transaction History